Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Mon, 23.10.2023
Eloro Resources Ltd.
The importance of ore sorting and stripping ratios
After Eloro Resources published the initial mineral resource estimate (MRE)
for the Iska Iska silver-tin polymetallic project in the Bolivian Potosi
Department, the share price came under significant pressure. We believe
this was based on certain misconceptions specifically about the impac [ … ]
Mon, 23.10.2023
ad pepper media International N.V.
First Berlin Equity Research hat ein Research Update zu ad pepper media
International N.V. (ISIN: NL0000238145) veröffentlicht. Analyst Dr. Karsten
von Blumenthal bestätigt seine BUY-Empfehlung und senkt das Kursziel von
EUR 3,50 auf EUR 3,00.
Zusammenfassung:
ad pepper media (APM) hat vorläufige Zahlen für das dritte Quarta [ … ]
Fri, 20.10.2023
First Tin Plc
Business Development 1. HY 2023
Overall, First Tin's first half of the year marked a period of significant
strategic progress, establishing a robust foundation for future development
and production that adheres to the highest environmental standards and
satisfies the growing demand for responsibly sourced tin. The company
achieved substant [ … ]
Thu, 19.10.2023
Sernova Corp
First Berlin Equity Research has initiated coverage on Sernova Corp (ISIN:
CA81732W1041). Analyst Christian Orquera's rating is BUY with a price
target of CAD3.80 (USD2.80; €2.60).
Abstract:
Sernova Corp (Sernova) is a Canadian, clinical-stage biotech company
developing cell therapeutics towards 'functional cures' for chronic
debilitating [ … ]
Thu, 19.10.2023
EasyMotionSkin Tec AG
EasyMotionSkin Tec AG is expanding its portfolio with the acquisition of
milongroup, a strategic move that solidifies the company's position in the
healthcare sector. As part of this development, mid-term forecast
adjustments are currently underway.
At an extraordinary general meeting, EasyMotionSkin Tec AG greenlit the
acquisition of milo [ … ]
Wed, 18.10.2023
MPH Health Care AG
First Berlin Equity Research hat ein Research Update zu MPH Health Care AG
(ISIN: DE000A289V03) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und erhöht das Kursziel von EUR 59,00 auf EUR 62,00.
Zusammenfassung:
Der Sechsmonatsbericht spiegelt die Kursentwicklung der beiden wichtigsten
börsennotierten B [ … ]
Wed, 18.10.2023
Klondike Gold Corp.
First Berlin Equity Research hat ein Research Update zu Klondike Gold Corp.
(ISIN: CA4989033010) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und bestätigt sein Kursziel von CAD 0,75.
Zusammenfassung:
Klondike Gold Corp. veröffentlichte ein Update zu seiner Explorations- und
Erschließungskampagne [ … ]
Wed, 18.10.2023
Rover Metals Corp.
Upgrading LGL’s project size to 33.6 sq km
After the acquisition of a further 2,400 acres, significantly enhancing the
total project size of Rover Metals’ most promising asset Let’s Go Lithium
(LGL) to approximately 8,300 acres or 33.6 sq km, we reiterate our Buy
rating for the shares of Rover Metals. However, the signifi [ … ]
Mon, 16.10.2023
CR Energy AG
First Berlin Equity Research hat ein Research Update zu CR Energy AG (ISIN:
DE000A2GS625) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und senkt das Kursziel von EUR 50,00 auf EUR 48,00.
Zusammenfassung:
Der Sechsmonatsbericht zeigt eine weitere gute Portfolioperformance, die
den Ruf der kürzlich umbenannte [ … ]
Thu, 12.10.2023
Valneva
First Berlin Equity Research has published a research update on Valneva SE
(ISIN: FR0004056851). Analyst Simon Scholes reiterated his BUY rating and
maintained his EUR 8.90 price target.
Abstract:
Both Q2/23 revenues and adjusted EBITDA were above our and consensus
forecasts and management has reiterated full-year product revenue guidance
of &e [ … ]